Japuntich, Sandra J.
Walaska, Kristen
Friedman, Elena Yuija
Balletto, Brittany
Cameron, Sarah
Tanzer, Joshua Ray
Fang, Pearl
Clark, Melissa A.
Carey, Michael P.
Fava, Joseph
Busch, Andrew M.
Breault, Christopher
Rosen, Rochelle
Funding for this research was provided by:
American Cancer Society (RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649, RSG CPHPS – 131649)
Article History
Received: 29 August 2023
Accepted: 28 May 2024
First Online: 7 June 2024
Declarations
:
: The study procedures received approval from the institutional review boards at both Lifespan and Hennepin Healthcare (#19-4677). Informed consent was obtained from all participants. A waiver of documentation of informed consent was obtained from both institutional review boards. All participants received a fact sheet containing all the elements of informed consent. Completion of the survey was considered consent to participate.
: Not applicable.
: Elena Friedman now works for Medtronic. She had no conflicts of interest at the time they worked on the study. No other authors have conflicts of interest to report. The sponsor had no role in design, data collection, analysis, writing or the decision to submit this paper for publication.